Fundz

Superluminal Medicines reported raising $20 Million in an initial SEC Form D filing, from an offering of $120 Million

PRIVATESep 04, 2024$20M of $120M raised

Amount Raised

$20 Million

$20 Million per company press release (Sep 9, 2024)

Round Type

Venture

BostonBiotechnologyHealth Care

Who to call at Superluminal Medicines, and when

A new round usually means Superluminal Medicines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Superluminal Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Superluminal Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Superluminal Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Superluminal Medicines

Location

Boston, Massachusetts, United States

About

Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Superluminal Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Superluminal Medicines's next move

See what Strategic adds

Superluminal Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.